[HTML][HTML] Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional …
…, JA Gietema, JA Langendijk, JH Maduro… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Purpose A relationship between mean heart dose (MHD) and acute coronary event (ACE)
rate was reported in a study of patients with breast cancer (BC). The main objective of our …
rate was reported in a study of patients with breast cancer (BC). The main objective of our …
The role of antibiotic prophylaxis in prevention of wound infection after Lichtenstein open mesh repair of primary inguinal hernia: a multicenter double-blind …
…, R van Nieuwenhuizen, E Hiemstra, JH Maduro… - Annals of …, 2004 - journals.lww.com
Objective: To determine whether the use of prophylactic antibiotics is effective in the prevention
of postoperative wound infection after Lichtenstein open mesh inguinal hernia repair. …
of postoperative wound infection after Lichtenstein open mesh inguinal hernia repair. …
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open …
…, P O'Brien, JA Harvey, C Kirkove, JH Maduro… - The Lancet, 2022 - thelancet.com
Background Whole breast irradiation (WBI) after conservative surgery for ductal carcinoma
in situ (DCIS) reduces local recurrence. We investigated whether a tumour bed boost after …
in situ (DCIS) reduces local recurrence. We investigated whether a tumour bed boost after …
Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo) radiation and survival in cervical cancer
…, H Hollema, HJG Arts, E Pras, JH Maduro… - Clinical cancer …, 2009 - AACR
Purpose: Activation of the epidermal growth factor receptor (EGFR) signaling pathway has
been reported to induce resistance to (chemo)radiation in cancers, such as head and neck …
been reported to induce resistance to (chemo)radiation in cancers, such as head and neck …
The cancer patient and cardiology
…, CP Gale, JH Maduro… - European journal of …, 2020 - Wiley Online Library
Advances in cancer treatments have improved clinical outcomes, leading to an increasing
population of cancer survivors. However, this success is associated with high rates of short‐ …
population of cancer survivors. However, this success is associated with high rates of short‐ …
Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy
HP Van Der Laan, WV Dolsma, JH Maduro… - International Journal of …, 2007 - Elsevier
Purpose: To compare the target coverage and normal tissue dose with the simultaneously
integrated boost (SIB) and the sequential boost technique in breast cancer, and to evaluate …
integrated boost (SIB) and the sequential boost technique in breast cancer, and to evaluate …
Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit
…, A Jager, M Lobbes, JH Maduro… - Journal of surgical …, 2017 - Wiley Online Library
Background In 2011, the NABON Breast Cancer Audit (NBCA) was instituted as a nation‐wide
audit to address quality of breast cancer care and guideline adherence in the Netherlands…
audit to address quality of breast cancer care and guideline adherence in the Netherlands…
[HTML][HTML] Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients
…, JM Schippers, H Struikmans, JH Maduro - Breast cancer research …, 2014 - Springer
Purpose In left-sided breast cancer radiotherapy, tangential intensity modulated radiotherapy
combined with breath-hold enables a dose reduction to the heart and left anterior …
combined with breath-hold enables a dose reduction to the heart and left anterior …
Proton therapy for breast cancer: A consensus statement from the Particle Therapy Cooperative Group Breast Cancer Subcommittee
…, LA McGee, JJ Urbanic, O Cahlon, JH Maduro… - International Journal of …, 2021 - Elsevier
Radiation therapy plays an important role in the multidisciplinary management of breast
cancer. Recent years have seen improvements in breast cancer survival and a greater …
cancer. Recent years have seen improvements in breast cancer survival and a greater …
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a …
…, P O'Brien, J Ludbrook, J Harvey, JH Maduro… - The Lancet …, 2020 - thelancet.com
Background BIG 3-07/TROG 07.01 is an international, multicentre, randomised, controlled,
phase 3 trial evaluating tumour bed boost and hypofractionation in patients with non-low-risk …
phase 3 trial evaluating tumour bed boost and hypofractionation in patients with non-low-risk …